TLDR Finasteride may reduce prostate cancer risk.
The Prostate Cancer Prevention Trial (PCPT) was a significant clinical study that explored the potential of reducing prostate cancer incidence through the daily intake of 5 mg of finasteride over 7 years. The study, published in the New England Journal of Medicine, was complex in its methodology. It aimed to highlight the key methodological aspects, present notable results, and discuss possible clinical applications in everyday urological practice.
11 citations
,
February 2004 in “Clinical and Experimental Ophthalmology” Taking Propecia might lead to the development of cataracts.
2 citations
,
September 2007 in “Fertility and Sterility” Stopping Propecia may improve sperm count and fertility.
3 citations
,
June 2004 in “Annales De Dermatologie Et De Venereologie” Four new cases of gynecomastia (male breast enlargement) linked to finasteride (Propecia) have been found.
2 citations
,
January 2003 in “Journal of Clinical Dermatology” 1 mg finasteride can cause reversible painful breast enlargement in men.
April 2012 in “Reactions Weekly” Finasteride may cause more sexual side effects than previously thought.
Finasteride is popular for treating male hair loss but may increase the risk of serious prostate cancer and has other potential side effects.